This content is in French.
Lipids and breast cancer: metabolic reprogramming as a therapeutic target
22 juillet 2025
By Lila Rouland | Published on July 22, 2025 | 2 min read
#BreastCancer #LipidMetabolism #FASN #Ferroptosis #TumorMicroenvironment
Breast cancer (BC) remains one of the most feared cancers, particularly among women aged 30 to 60. While therapeutic advances have improved survival rates, a harsh reality persists: some tumors resist treatment, recur, or metastasize. Why? A remarkable ability of tumor cells to reprogram their lipid metabolism. This is one of the key insights highlighted in a recent review published in Molecular Cancer.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Wan, M., Pan, S., Shan, B., et al. (2025). Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment. Molecular Cancer, 24(1), 61.
View the source
